Isolated Non-Secretory Extramedullary Relapse of Multiple Myeloma Responded Completely to Localized Radiotherapy
Open Access
- 1 January 2024
- journal article
- research article
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 17 (1) , 423-429
Abstract
Introduction: Non-secretory multiple myeloma (NSMM) is a rare form of multiple myeloma (MM) that is often difficult to detect and has not yet been well characterized. This is due to the lack of production or the presence of monoclonal protein (MP) levels below levels detectable by testing such as serum/urine electrophoresis and immunofixation. Case Presentation: Two patients of ours were being treated for MM with typical courses of systemic therapy. By the third-line therapy, both developed an extramedullary mass, one in the pelvis and the other in the neck. In both cases, blood work showed no measurable MP, normal free light chain levels, and unremarkable skeletal surveys. Secondary malignancies were suspected due to the clinical presentation in each case, and biopsies confirmed the presence of non-secretory plasmacytomas. Both patients were only treated with localized radiotherapy with a total dose of 2,000 cGy in 5 fractions over 1 week. Ultimately, this resolved the original masses with no residual tumors. No changes had to be made to their systemic therapies, and both patients remained stable. Conclusion: NSMM relapse is not unusual and should be suspected in patients with relapsed refractory disease. Relapse should be confirmed by a tissue biopsy, and secondary malignancies should be ruled out. Radiotherapy is an excellent option to treat localized relapse and preserve the current line of systemic anti-myeloma therapy.Keywords
This publication has 11 references indexed in Scilit:
- Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaAmerican Journal of Hematology, 2023
- Isolated coagulopathy without classic CRAB symptoms as the initial manifestation of multiple myeloma: A case reportWorld Journal of Clinical Cases, 2022
- Extramedullary disease in multiple myeloma: a systematic literature reviewBlood Cancer Journal, 2022
- Multiple Myeloma Oligosecretory Relapse, a Non-Negligible Phenomenon. Frequency, Clinical Characteristics and Outcomes in a Single CenterBlood, 2021
- Non-secretory multiple myeloma: Diagnosis and managementAdvances in Clinical and Experimental Medicine, 2021
- Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic ImplicationsDiagnostics, 2021
- Second malignancies in multiple myeloma; emerging patterns and future directionsBest Practice & Research Clinical Haematology, 2020
- NON-SECRETORY MYELOMA: READY FOR A NEW DEFINITION?Mediterranean Journal of Hematology and Infectious Diseases, 2016
- Non-secretory multiple myeloma: from biology to clinical managementOncoTargets and Therapy, 2016
- The possible role of burden of therapy on the risk of myeloma extramedullary spreadAnnals of Hematology, 2016